Want to see SI full AI Analyst Report?
SI Stock Chart & Stats
$14.54
<$0.01(0.07%)
At close: 4:00 PM EDT
$14.54
<$0.01(0.07%)
Day’s Range― - ―
52-Week Range$10.92 - $22.92
Previous Close$15.29
Volume91.20K
Average Volume (3M)130.13K
Market Cap
$441.10M
Enterprise Value$376.18M
Total Cash (Recent Filing)$108.54M
Total Debt (Recent Filing)$15.01M
Price to Earnings (P/E)―
Beta-0.15
Next Earnings
Sep 15, 2026EPS Estimate
-0.46Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-2.17
Shares Outstanding20,738,226
10 Day Avg. Volume53,279
30 Day Avg. Volume130,135
Financial Highlights & Ratios
PEG Ratio-0.05
Price to Book (P/B)1.90
Price to Sales (P/S)6.23
P/FCF Ratio-8.19
Enterprise Value/Market Cap0.85
Enterprise Value/Revenue6.98
Enterprise Value/Gross Profit9.25
Enterprise Value/Ebitda-9.14
Forecast
1Y Price Target
$21.00Price Target Upside44.43% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering3
EPS Forecast (FY)-1.7
Revenue Forecast (FY)$67.34M
Bulls Say, Bears Say
Bulls Say
Rapid Revenue Growth And Surgeon AdoptionSustained double‑digit revenue and unit growth driven by surgeon adoption indicate durable demand. Expanding surgeon funnel and rising utilization create a scalable commercial base that supports long‑term revenue predictability and gives the company leverage to spread fixed costs as volumes grow.
High And Stable Gross MarginsConsistently strong gross margins reflect attractive unit economics for implant sales, supporting intrinsic profitability as revenue scales. Durable margin levels provide room to invest in R&D and commercial expansion while preserving the path to improved operating margins if overhead growth moderates.
Strengthened Liquidity And Credit FlexibilityA sizable cash balance plus a newly structured term loan and undrawn revolver materially extend operational runway and reduce immediate refinancing risk. Improved debt economics and longer maturities give management time to execute commercialization and pursue breakeven without urgent capital raises.
Bears Say
Accelerating Cash BurnMeaningful and worsening negative operating and free cash flow signal the business still relies on external financing to fund growth. Persistent cash burn raises funding risk if capital markets tighten and increases pressure to achieve the management‑stated path to cash‑flow breakeven within the planning horizon.
Widening Operating Losses From Expense RampRapid increases in SG&A and R&D have outpaced revenue growth at the operating line, widening EBITDA and net losses. If operating expense growth remains elevated during scaling, it could delay sustainable profitability and compress eventual equity returns despite strong top‑line trends.
Seasonality And ASP/mix Variability RiskMeaningful quarter‑to‑quarter swings from seasonality and product/payer mix complicate revenue and margin predictability. That variability can stress working capital and covenant tests, making it harder to forecast the timing of breakeven and to reliably meet springing revenue requirements in credit agreements.
SI FAQ
What was Shoulder Innovations, Inc.’s price range in the past 12 months?
Shoulder Innovations, Inc. lowest stock price was $10.92 and its highest was $22.92 in the past 12 months.
What is Shoulder Innovations, Inc.’s market cap?
Shoulder Innovations, Inc.’s market cap is $441.10M.
When is Shoulder Innovations, Inc.’s upcoming earnings report date?
Shoulder Innovations, Inc.’s upcoming earnings report date is Sep 15, 2026 which is in 73 days.
How were Shoulder Innovations, Inc.’s earnings last quarter?
Shoulder Innovations, Inc. released its earnings results on May 13, 2026. The company reported -$0.41 earnings per share for the quarter, the consensus estimate of -$0.41 by $0.
Is Shoulder Innovations, Inc. overvalued?
According to Wall Street analysts Shoulder Innovations, Inc.’s price is currently Undervalued.
Does Shoulder Innovations, Inc. pay dividends?
Shoulder Innovations, Inc. does not currently pay dividends.
What is Shoulder Innovations, Inc.’s EPS estimate?
Shoulder Innovations, Inc.’s EPS estimate is -0.46.
How many shares outstanding does Shoulder Innovations, Inc. have?
Shoulder Innovations, Inc. has 20,738,226 shares outstanding.
What happened to Shoulder Innovations, Inc.’s price movement after its last earnings report?
Shoulder Innovations, Inc. reported an EPS of -$0.41 in its last earnings report, expectations of -$0.41. Following the earnings report the stock price went up 15.225%.
Which hedge fund is a major shareholder of Shoulder Innovations, Inc.?
Currently, no hedge funds are holding shares in SI
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Shoulder Innovations, Inc. Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$21.00 (44.43% Upside)
$21.00 (44.43% Upside)
Hedge Fund Trend
Decreased
By 482.6K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.3%
Last 30 Days ▼ 8.9%
Last 30 Days ▼ 8.9%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Fundamentals
Return on Equity
-35.31%
Trailing 12-Months
Asset Growth
178.77%
Trailing 12-Months
Company Description
Shoulder Innovations, Inc.
Shoulder Innovations, Inc. manufactures medical devices. It has developed a shoulder replacement system. The company was founded by Stephen B. Gunther and Michael DeVries in 2009 and is headquartered in Grand Rapids, MI.
SI Earnings Call
Q1 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call presented a strong operating and commercial momentum: sizable revenue and volume growth, improving gross margins, accelerating surgeon adoption and meaningful product and technology milestones (I-135 full launch, N22 limited release, >500 patients in registry, and a progressing robotic partnership). These positives were offset by increased operating expenses and larger net and adjusted EBITDA losses as the company invests to scale, a Q1 cash burn driven by inventory and working capital, and some seasonality and ASP/mix variability risk embedded in the updated guidance. Overall, management expressed high conviction in the trajectory and raised full-year guidance while noting near-term investment-related impacts.View all SI earnings summariesSI Stock 12 Month Forecast
Average Price Target
$21.00
▲(44.43% Upside)
Technical Analysis
Ownership Overview
58.76% Insiders
14.15% Mutual Funds
7.87% Other Institutional Investors
14.96% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---










